These findings suggest the potentiality of radiation‐guided technology to enhance the reliability of PSMA PET‐guided biopsy, providing immediate confirmation of lesion presence during surgery, and could improve biopsy outcomes in prostate cancer diagnosis. This evidence concerns the gene FOLH1 and prostate carcinoma.